Ionis Pharmaceuticals, Inc. (IONS)

Ionis Pharmaceuticals Revenue

Ionis Pharmaceuticals had revenue of $133.81M in the quarter ending September 30, 2024, a decrease of -7.21%. This brings the company's revenue in the last twelve months to $803.07M, up 30.57% year-over-year. In the year 2023, Ionis Pharmaceuticals had annual revenue of $787.65M with 34.10% growth.

• Revenue (ttm): $803.07M
• Revenue Growth: +30.57%
• P/S Ratio: 5.80
• Revenue / Employee: $866,307
• Employees: 927
• Market Cap: 5.04B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2023	787.65M	200.28M	34.10%
Dec 31, 2022	587.37M	-223.09M	-27.53%
Dec 31, 2021	810.46M	81.19M	11.13%
Dec 31, 2020	729.26M	-393.34M	-35.04%
Dec 31, 2019	1.12B	522.93M	87.20%

Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.